Church & Dwight Gains Orajel With $380 Million Del OTC Purchase
This article was originally published in The Rose Sheet
Executive Summary
Church & Dwight has agreed to acquire Del Pharmaceuticals' OTC brands, including the Orajel topical analgesic line, for $380 million in cash from Coty, Inc., the firm said April 1